307
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Anxiety and Depression Among US Nursing Home Residents with Chronic Obstructive Pulmonary Disease

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1867-1882 | Received 13 May 2023, Accepted 11 Aug 2023, Published online: 28 Aug 2023

References

  • Celli BR, Wedzicha JA. Update on clinical aspects of chronic obstructive pulmonary disease. N Engl J Med. 2019;381(13):1257–1266.
  • World Health Organization. The top 10 causes of death; 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed March 08, 2023.
  • Xu J, Murphy SL, Kockanek KD, Arias E. Mortality in the United States, 2018. NCHS Data Brief. 2020;355:1–8.
  • Wheaton AG, Liu Y, Croft JB, et al. Chronic obstructive pulmonary disease and smoking status - United States, 2017. MMWR Morb Mortal Wkly Rep. 2019;68(24):533–538. doi:10.15585/mmwr.mm6824a1
  • Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi:10.1371/journal.pmed.0030442
  • Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940. doi:10.1016/S0140-6736(17)31222-9
  • Spillman BC, Lubitz J. New estimates of lifetime nursing home use: have patterns of use changed? Med Care. 2002;40(10):965–975. doi:10.1097/00005650-200210000-00013
  • Pleasants R. Chronic obstructive pulmonary disease in long-term care. Ann Longterm Care. 2009;17:24–30.
  • Zarowitz BJ, O’Shea T. Chronic obstructive pulmonary disease: prevalence, characteristics, and pharmacologic treatment in nursing home residents with cognitive impairment. J Manag Care Pharm. 2012;18(8):598–606. doi:10.18553/jmcp.2012.18.8.598
  • Excellence NIoHaC. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. NG115; 2019. Available from: https://www.nice.org.uk/guidance/ng115. Accessed February 23, 2023.
  • Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP
  • Care IoMUCoIQiL-T. Improving the Quality of Long-Term Care. Washington (DC): National Academies Press (US); 2001.
  • Centers for Medicare & Medicaid Services. Long-Term Care Facility Resident Assessment Instrument 3.0 User’s Manual. Department of Health & Human Services, ed; 2016.
  • Medicare Cf, Services M. Long-term care facility resident assessment instrument 3.0 user’s manual. Accessed May. 2015;9:2016.
  • Saliba D, DiFilippo S, Edelen MO, Kroenke K, Buchanan J, Streim J. Testing the PHQ-9 interview and observational versions (PHQ-9 OV) for MDS 3.0. J Am Med Dir Assoc. 2012;13(7):618–625. doi:10.1016/j.jamda.2012.06.003
  • Bova CA, Jesdale BM, Mbrah A, Botelho L, Lapane KL. Development and psychometric evaluation of the social connectedness index in nursing home residents with Alzheimer’s disease and dementia using the minimum data set 3.0. Int J Geriatr Psychiatry. 2021;36(7):1110–1119. doi:10.1002/gps.5516
  • Morris JN, Fries BE, Morris SA. Scaling ADLs within the MDS. J Gerontol a Biol Sci Med Sci. 1999;54(11):M546–M553. doi:10.1093/gerona/54.11.M546
  • Thomas KS, Dosa D, Wysocki A, Mor V. The minimum data set 3.0 cognitive function scale. Med Care. 2017;55(9):e68–e72. doi:10.1097/MLR.0000000000000334
  • Chodosh J, Edelen MO, Buchanan JL, et al. Nursing home assessment of cognitive impairment: development and testing of a brief instrument of mental status. J Am Geriatr Soc. 2008;56(11):2069–2075. doi:10.1111/j.1532-5415.2008.01944.x
  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
  • Cheok A, Snowdon J, Miller R, Vaughan R. The prevalence of anxiety disorders in nursing homes. Int J Geriatr Psychiatry. 1996;11:405–410. doi:10.1002/(SICI)1099-1166(199605)11:5<405::AID-GPS302>3.0.CO;2-O
  • Rovner BW, Kafonek S, Filipp L, Lucas MJ, Folstein MF. Prevalence of mental illness in a community nursing home. Am J Psychiatry. 1986;143(11):1446–1449.
  • Junginger J, Phelan E, Cherry K, Levy J. Prevalence of psychopathology in elderly persons in nursing homes and in the community. Psychiatr Serv. 1993;44(4):381–383. doi:10.1176/ps.44.4.381
  • Parmelee PA, Katz IR, Lawton MP. Anxiety and its association with depression among institutionalized elderly. Am J Geriatr Psychiatry. 1993;1(1):46–58. doi:10.1097/00019442-199300110-00007
  • Hynninen KM, Breitve MH, Wiborg AB, Pallesen S, Nordhus IH. Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. J Psychosom Res. 2005;59(6):429–443. doi:10.1016/j.jpsychores.2005.04.007
  • Flint AJ. Epidemiology and comorbidity of anxiety disorders in the elderly. Am J Psychiatry. 1994;151(5):640–649.
  • Beekman AT, Bremmer MA, Deeg DJ, et al. Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam. Int J Geriatr Psychiatry. 1998;13(10):717–726. doi:10.1002/(SICI)1099-1166(1998100)13:10<717::AID-GPS857>3.0.CO;2-M
  • Forsell Y, Winblad B. Feelings of anxiety and associated variables in a very elderly population. Int J Geriatr Psychiatry. 1998;13(7):454–458. doi:10.1002/(SICI)1099-1166(199807)13:7<454::AID-GPS795>3.0.CO;2-D
  • Lenze EJ, Rogers JC, Martire LM, et al. The association of late-life depression and anxiety with physical disability: a review of the literature and prospectus for future research. Am J Geriatr Psychiatry. 2001;9(2):113–135. doi:10.1097/00019442-200105000-00004
  • McLean CP, Asnaani A, Litz BT, Hofmann SG. Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. J Psychiatr Res. 2011;45(8):1027–1035. doi:10.1016/j.jpsychires.2011.03.006
  • Regier DA, Farmer ME, Rae DS, et al. One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the Epidemiologic Catchment Area study. Acta Psychiatr Scand. 1993;88(1):35–47. doi:10.1111/j.1600-0447.1993.tb03411.x
  • De Bellis A. Opinion piece: Australian residential aged care and the quality of nursing care provision. Contemp Nurse. 2010;35(1):100–113. doi:10.5172/conu.2010.35.1.100
  • Ulbricht CM, Hunnicutt JN, Hume AL, Lapane KL. Depression, anxiety, and pain among newly admitted nursing home residents. J Nurs Home Res Sci. 2019;5:40–48. doi:10.14283/jnhrs.2019.8
  • Crump C, Sundquist K, Sundquist J, Winkleby MA. Sociodemographic, psychiatric and somatic risk factors for suicide: a Swedish national cohort study. Psychol Med. 2014;44(2):279–289. doi:10.1017/S0033291713000810
  • Goodwin RD. Is COPD associated with suicide behavior? J Psychiatr Res. 2011;45(9):1269–1271. doi:10.1016/j.jpsychires.2011.01.014
  • Webb RT, Kontopantelis E, Doran T, Qin P, Creed F, Kapur N. Suicide risk in primary care patients with major physical diseases: a case-control study. Arch Gen Psychiatry. 2012;69(3):256–264. doi:10.1001/archgenpsychiatry.2011.1561
  • Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006;31(1):58–69. doi:10.1016/j.jpainsymman.2005.06.007
  • Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–161. doi:10.1164/rccm.201201-0034OC
  • Jose AK, Chelangara DP, Shaji K. Factors associated with anxiety and depression in chronic obstructive pulmonary disease. Int J Res Med Sci. 2016;4(4):1074–1079. doi:10.18203/2320-6012.ijrms20160786
  • Tsai T-Y, Livneh H, M-c L, Tsai P-Y, Chen P-C, Sung F-C. Increased risk and related factors of depression among patients with COPD: a population-based cohort study. BMC Public Health. 2013;13(1):976. doi:10.1186/1471-2458-13-976
  • Perini G, Cotta Ramusino M, Sinforiani E, Bernini S, Petrachi R, Costa A. Cognitive impairment in depression: recent advances and novel treatments. Neuropsychiatr Dis Treat. 2019;15:1249–1258. doi:10.2147/NDT.S199746
  • McAllister TW, Price TR. Severe depressive pseudodementia with and without dementia. Am J Psychiatry. 1982;139(5):626–629.
  • Brodaty H, Connors MH. Pseudodementia, pseudo-pseudodementia, and pseudodepression. Alzheimers Dement. 2020;12(1):e12027. doi:10.1002/dad2.12027
  • Kramer D, Allgaier A-K, Fejtkova S, Mergl R, Hegerl U. Depression in nursing homes: prevalence, recognition, and treatment. Int J Psychiatr Med. 2009;39(4):345–358. doi:10.2190/PM.39.4.a
  • Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. 2013;144(3):766–777. doi:10.1378/chest.12-1911
  • Laforest L, Roche N, Devouassoux G, et al. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: a population-based cohort study. Respir Med. 2016;117:33–39. doi:10.1016/j.rmed.2016.05.019
  • Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;23(133):345–349. doi:10.1183/09059180.00007813
  • Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134(4 Suppl):43s–56s. doi:10.1378/chest.08-0342
  • Vozoris NT, Wang X, Austin PC, et al. Serotonergic antidepressant use and morbidity and mortality among older adults with COPD. Eur Respir J. 2018;52(1). doi:10.1183/13993003.00475-2018
  • George J, Kong DC, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest. 2005;128(5):3198–3204. doi:10.1378/chest.128.5.3198
  • Morrison D, Agur K, Mercer S, Eiras A, González-Montalvo JI, Gruffydd-Jones K. Managing multimorbidity in primary care in patients with chronic respiratory conditions. NPJ Prim Care Respir Med. 2016;26:16043. doi:10.1038/npjpcrm.2016.43
  • Coventry PA, Hind D. Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: systematic review and meta-analysis. J Psychosom Res. 2007;63(5):551–565. doi:10.1016/j.jpsychores.2007.08.002
  • Gordon CS, Waller JW, Cook RM, Cavalera SL, Lim WT, Osadnik CR. Effect of pulmonary rehabilitation on symptoms of anxiety and depression in COPD: a systematic review and meta-analysis. Chest. 2019;156(1):80–91. doi:10.1016/j.chest.2019.04.009
  • Coventry PA, Gellatly JL. Improving outcomes for COPD patients with mild-to-moderate anxiety and depression: a systematic review of cognitive behavioural therapy. Br J Health Psychol. 2008;13(Pt 3):381–400. doi:10.1348/135910707X203723
  • Usmani ZA, Carson KV, Heslop K, Esterman AJ, De Soyza A, Smith BJ. Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;3. doi:10.1002/14651858.CD010673.pub2
  • Huang FY, Chung H, Kroenke K, Delucchi KL, Spitzer RL. Using the patient health questionnaire-9 to measure depression among racially and ethnically diverse primary care patients. J Gen Intern Med. 2006;21(6):547–552. doi:10.1111/j.1525-1497.2006.00409.x
  • Merz EL, Malcarne VL, Roesch SC, Riley N, Sadler GR. A multigroup confirmatory factor analysis of the patient health questionnaire-9 among English- and Spanish-speaking latinas. Cultur Divers Ethnic Minor Psychol. 2011;17(3):309–316. doi:10.1037/a0023883
  • Bélanger E, Thomas KS, Jones RN, Epstein-Lubow G, Mor V. Measurement validity of the patient-health questionnaire-9 in US nursing home residents. Int J Geriatr Psychiatry. 2019;34(5):700–708. doi:10.1002/gps.5074
  • Potter GG, Steffens DC. Contribution of depression to cognitive impairment and dementia in older adults. Neurologist. 2007;13(3):105–117. doi:10.1097/01.nrl.0000252947.15389.a9